Cytogenetics

The Victorian Cancer Cytogenetics service is a fully NATA/RCPA accredited laboratory which provides a state wide service for cancer cytogenetic analysis.

Cytogenetics has become an integral part of the management of haematological and other malignancies by providing important diagnostic and prognostic information. As a marker of disease status cytogenetics can be used to assess remission or relapse, including the monitoring of patients post bone marrow transplantation.


About Us

AboutUs

The Victorian Cancer Cytogenetics service is a fully NATA/RCPA accredited laboratory which provides a state wide service for cancer cytogenetic analysis.

Understanding Leukaemia

UnderstandingLeukaemia

This project studies some of the poorly studied gene errors in complex karyotype AML and MDS. It also aims to identify some of the mechanisms causing them.

Background

Background

Acute myeloid leukaemia (AML) and myelodysplastic syndromes (MDS) are malignancies of the bone marrow. Around a third of MDS patients will develop AML.

Sponsors

Sponsors

We thank our past and current sponsors for supporting this research.

Donate

Donations

The funding of this research is imperative to pursue the increasing benefits and findings of Dr MacKinnon’s work to date.

Selected Publications

SelectedPublications

MacKinnon RN, Wall M, Zordan A, Nutalapati S, Mercer B, Peverall J and Campbell LJ 2013. Genome organisation and the role of centromeres in evolution of the erythroleukaemia cell line HEL. Evol Med Publ Health 2013:225-240